Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Medtronic
Baxter
Johnson and Johnson
Dow

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Sotagliflozin

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Sotagliflozin: Sponsors, patents, clinical trial progress

Sotagliflozin is an investigational drug.

There have been 33 clinical trials for Sotagliflozin. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2019.

The most common disease conditions in clinical trials are Diabetes Mellitus, Diabetes Mellitus, Type 2, and Diabetes Mellitus, Type 1. The leading clinical trial sponsors are Sanofi, Lexicon Pharmaceuticals, and The University of Texas Health Science Center at San Antonio.

There are thirteen US patents protecting this investigational drug and one hundred and sixty-nine international patents.

Recent Clinical Trials for Sotagliflozin
TitleSponsorPhase
Dapagliflozin Plus Pioglitazone in T1DMThe University of Texas Health Science Center at San AntonioPhase 4
Sotagliflozin Multiple-dose Phase I Study in Healthy Chinese SubjectsSanofiPhase 1
Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without SulfonylureaSanofiPhase 3

See all Sotagliflozin clinical trials

Clinical Trial Summary for Sotagliflozin

Top disease conditions for Sotagliflozin
Top clinical trial sponsors for Sotagliflozin

See all Sotagliflozin clinical trials

US Patents for Sotagliflozin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Sotagliflozin   See Pricing Inhibitors of sodium glucose co-transporter 2 and methods of their use Lexicon Pharmaceuticals, Inc. (The Woodlands, TX)   See Pricing
Sotagliflozin   See Pricing Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use Lexicon Pharmaceuticals, Inc. (The Woodlands, TX)   See Pricing
Sotagliflozin   See Pricing Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors Lexicon Pharmaceuticals, Inc. (The Woodlands, TX)   See Pricing
Sotagliflozin   See Pricing Solid forms of (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetr- ahydro-2H-pyran-3,4,5-triol and methods of their use Lexicon Pharmaceuticals, Inc. (The Woodlands, TX)   See Pricing
Sotagliflozin   See Pricing Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors Lexicon Pharmaceuticals, Inc. (The Woodlands, TX)   See Pricing
Sotagliflozin   See Pricing Sulfanyl-tetrahydropyran-based compounds and methods of their use Lexicon Pharmaceuticals, Inc. (The Woodlands, TX)   See Pricing
Sotagliflozin   See Pricing Bilayer tablet formulations Bristol-Myers Squibb Company (Princeton, NJ) AstraZeneca UK Limited (London, GB)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Sotagliflozin

Drugname Country Document Number Estimated Expiration Related US Patent
Sotagliflozin Argentina 063047 2026-09-29   See Pricing
Sotagliflozin Austria 496888 2026-09-29   See Pricing
Sotagliflozin Australia 2007304971 2026-09-29   See Pricing
Sotagliflozin Brazil PI0717156 2026-09-29   See Pricing
Sotagliflozin Canada 2664688 2026-09-29   See Pricing
Sotagliflozin China 101343296 2026-09-29   See Pricing
Sotagliflozin China 103254119 2026-09-29   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Medtronic
Moodys
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.